Drug profile · INN
gadopentetate dimeglumine
MAGNEVIST
gadopentetate dimeglumine (MAGNEVIST) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.
Drug details — gadopentetate dimeglumine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
gadopentetate dimeglumine (MAGNEVIST) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is gadopentetate dimeglumine?
gadopentetate dimeglumine (MAGNEVIST) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for gadopentetate dimeglumine?
MAGNEVIST is a marketed brand name for gadopentetate dimeglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gadopentetate dimeglumine?
gadopentetate dimeglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.